Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Gibco™ CD CHO AGT™ Medium
Click to view available options
Quantity:
10 kg
Description
CD CHO AGT™ (Advanced Granulation Technology) medium is a protein-free, chemically-defined medium optimized for the growth of Chinese hamster ovary (CHO) cells and expression of recombinant proteins in suspension culture. The AGT™ dry media format is designed to provide increased consistency and productivity across all stages of production from development to commercial manufacturing. CD CHO AGT™ medium contains no proteins or peptide components of animal, plant, or synthetic origin, as well as no undefined lysates or hydrolysates.
When to Use CD CHO Medium
Your GS CHO cells are recommended to be grown in CD CHO medium
Your cells have been successfully cultured in CD CHO medium in the past and your process is nearing a regulatory filing (DMF available)
When to Consider Another Gibco™ Medium
Consider CD FortiCHO™ medium when:
The cell line you are using is a transfected CHO K1, GS CHO or CHO-S™ cell line
Maximum batch culture cell densities and protein titers are needed
You have time to adapt cells into a new medium in an effort to maximize titers
Cell health at harvest is a priority for downstream processing
Consider CD OptiCHO™ medium when:
You are using a transfected CHO cell line other than CHO K1, GS CHO or CHO-S™ cell lines
Optimization of feeding strategies will be part of your base medium selection testing in an effort to maximize productivity
Your CHO cell line is finicky, i.e. hard to grow or adapt
Consider CD DG44 medium when:
You use parental DG44 or DXB11 CHO cells (dhfr-)
Liquid Media Formulations
Gibco™ AGT™ media are also available in a liquid format that offers the same performance and formulation as the AGT™ media format. Gibco™ liquid media are manufactured animal origin-free with the same complete, serum-free, protein-free, chemically-defined formulation and performance as their AGT™ media counterparts.
Design Your Own Media Specific to Your Needs
Whether it’s a bench-level experiment or large scale biomanufacturing process, we offer specialized formats, packaging, and quality levels specific to your needs. With Gibco™ cGMP Media Custom Services you can put the manufacturing power and years of technical experience of our R&D and Bioproduction Application Specialists to work for you.
When to Use CD CHO Medium
When to Consider Another Gibco™ Medium
Consider CD FortiCHO™ medium when:
Consider CD OptiCHO™ medium when:
Consider CD DG44 medium when:
Liquid Media Formulations
Gibco™ AGT™ media are also available in a liquid format that offers the same performance and formulation as the AGT™ media format. Gibco™ liquid media are manufactured animal origin-free with the same complete, serum-free, protein-free, chemically-defined formulation and performance as their AGT™ media counterparts.
Design Your Own Media Specific to Your Needs
Whether it’s a bench-level experiment or large scale biomanufacturing process, we offer specialized formats, packaging, and quality levels specific to your needs. With Gibco™ cGMP Media Custom Services you can put the manufacturing power and years of technical experience of our R&D and Bioproduction Application Specialists to work for you.
Specifications
Specifications
Cell Line | CHO |
Classification | Animal Origin-free, Chemically-defined, Protein-free, Serum-free |
Form | Powder (AGT) |
Product Type | CD CHO Medium |
Serum Level | Serum-free |
Sterility | Non-sterile |
With Additives | High Glucose, Sodium Bicarbonate, Sodium Pyruvate |
Without Additives | No Glutamine, No HEPES, No Phenol Red, No Thymidine, No Hypoxanthine |
Glucose Concentration | 6.33 g/L |
Product Line | AGT™, Gibco™ |
Show More |
For Research Use Only. Not for use in diagnostic procedures.
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction